July 9, 2020 / 9:52 AM / a month ago

BRIEF-Applied Dna Sciences - Forms Clinical Testing Subsidiary To Maximize Utility Of FDA Eua-Approved Linea™ Covid-19 Assay Kit

Applied DNA Sciences Inc:

* APPLIED DNA SCIENCES - FORMS CLINICAL TESTING SUBSIDIARY TO MAXIMIZE UTILITY OF FDA EUA-APPROVED LINEA™ COVID-19 ASSAY KIT

* APPLIED DNA SCIENCES - SUBSIDIARY TO ADVANCE COMMERCIAL DEVELOPMENT OF DIAGNOSTIC TESTS FOR VIROLOGY, COVID-19, ONCOLOGY

* CURRENTLY IN NEGOTIATIONS FOR FIRST COVID-19 TESTING CONTRACTS

* FORMATION OF A WHOLLY-OWNED SUBSIDIARY, APPLIED DNA CLINICAL LABS

* APPLIED DNA SCIENCE-ADCL ALSO FORMED TO FACILITATE USE AND DEVELOPMENT OF CO’S LIQUID BIOPSY PLATFORM FOR DETECTING ICTCS IN BLOOD OF CANCER PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below